1 Kim, J. S. H. Leprosy in Korea: A global history. (University of California, Los Angeles, 2012).
2 Jane, S. H. K. Leprosy and Citizenship in Korea under American Occupation (1945~1948). Sahak Yonku : The Review of Korean History, 253-283 (2010).
3 Anthony, M. (LWW, 2019).
4 Wolf, R., Matz, H., Orion, E., Tuzun, B. & Tuzun, Y. Dapsone. Dermatol Online J8, 2 (2002).
5 Wozel, V. E. Innovative use of dapsone. Dermatol Clin28, 599-610, doi:10.1016/j.det.2010.03.014 (2010).
6 Salehzadeh, F., Jahangiri, S. & Mohammadi, E. Dapsone as an alternative therapy in children with familial Mediterranean fever. Iranian Journal of Pediatrics22, 23 (2012).
7 Park, Y. H. et al. Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis. Nat Immunol21, 857-867, doi:10.1038/s41590-020-0705-6 (2020).
8 Calligaris, L., Marchetti, F., Tommasini, A. & Ventura, A. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever. Eur J Pediatr167, 695-696, doi:10.1007/s00431-007-0547-3 (2008).
9 Kanwar, B., Lee, C. J. & Lee, J.-H. Specific Treatment Exists for SARS-CoV-2 ARDS. Vaccines9, 635 (2021).
10 Zhang, F. R. et al. HLA-B*13:01 and the dapsone hypersensitivity syndrome. N Engl J Med369, 1620-1628, doi:10.1056/NEJMoa1213096 (2013).
11 Tempark, T. et al. Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population. Pharmacogenet Genomics27, 429-437, doi:10.1097/fpc.0000000000000306 (2017).
12 Watanabe, H. et al. A docking model of dapsone bound to HLA-B* 13: 01 explains the risk of dapsone hypersensitivity syndrome. Journal of dermatological science88, 320-329 (2017).
13 Chakraborty, A., Panda, A. K., Ghosh, R. & Biswas, A. DNA minor groove binding of a well known anti-mycobacterial drug dapsone: A spectroscopic, viscometric and molecular docking study. Arch Biochem Biophys665, 107-113, doi:10.1016/j.abb.2019.03.001 (2019).
14 Zhao, Q. et al. Dapsone‐and nitroso dapsone‐specific activation of T cells from hypersensitive patients expressing the risk allele HLA‐B* 13: 01. Allergy74, 1533-1548 (2019).
15 Moon, C. Fighting COVID-19 exhausts T cells. Nature Reviews Immunology20, 277-277, doi:10.1038/s41577-020-0304-7 (2020).
16 Heidel, F. & Hochhaus, A. (Nature Publishing Group, 2020).
17 Yao, Y. et al. Antigen-specific CD8+ T cell feedback activates NLRP3 inflammasome in antigen-presenting cells through perforin. Nature Communications8, 15402, doi:10.1038/ncomms15402 (2017).
18 Littera, R. et al. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience. Frontiers in immunology11, 605688-605688, doi:10.3389/fimmu.2020.605688 (2020).
19 Littera, R. et al. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection. PLOS ONE16, e0255608, doi:10.1371/journal.pone.0255608 (2021).
20 Vora, S. M., Lieberman, J. & Wu, H. Inflammasome activation at the crux of severe COVID-19. Nature Reviews Immunology, doi:10.1038/s41577-021-00588-x (2021).
21 Lee, J. H., Choi, S. H., Lee, C. J. & Oh, S. S. Recovery of Dementia Syndrome following Treatment of Brain Inflammation. Dement Geriatr Cogn Dis Extra10, 1-12, doi:10.1159/000504880 (2020).
22 Lee, J.-h., Lee, Chul J., Park, J., Lee, So J. & Choi, S.-h. The Neuroinflammasome in Alzheimer’s Disease and Cerebral Stroke. Dementia and Geriatric Cognitive Disorders Extra11, 159-167, doi:10.1159/000516074 (2021).
23 Lee, J.-h., An, H. K., Sohn, M.-G., Kivela, P. & Oh, S. 4,4′-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor. International Journal of Molecular Sciences21, 5953 (2020).
24 Khattak, A. et al. Commentary for the Elderly in the Pandemic Era. Dementia and Geriatric Cognitive Disorders Extra11, 168-171, doi:10.1159/000515926 (2021).
25 Han, J. W. et al. Overview of the Korean Longitudinal Study on Cognitive Aging and Dementia. Psychiatry Investig15, 767-774, doi:10.30773/pi.2018.06.02 (2018).
26 Lee, J. H. The Regulatory Capture in the National Health Insurance System of South Korea. (INFOMEDPRESS, 2021).
27 Ramos-e-Silva, M. & Rebello, P. F. B. Leprosy. American journal of clinical dermatology2, 203-211 (2001).
28 Yuan, S. et al. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2. Nature593, 418-423, doi:10.1038/s41586-021-03431-4 (2021).
29 Chae, G. T. Modern History of Hansen's Disease in Korea. Infect Chemother52, 647-653, doi:10.3947/ic.2020.52.4.647 (2020).
30 Lee, J.-h. The Preventive and Treatment of the Neuroinflammasome in Sorokdo National Hospital. under review, doi:10.21203/rs.3.rs-243831/v4 (2021).
31 Cho, Y., Shim, E., Lee, K.-S. & Park, S. C. Mortality profiles of leprosy-affected elderly in Korea: A demographic perspective. Asia-Pacific E-Journal of Health Social Science3, pp. 1-5, doi:https://sites.google.com/site/asiapacificejournalofhss/journal-issues/june-2014 (2014).
32 Colella, M. P. et al. A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response. J Thromb Haemostn/a, doi:10.1111/jth.15396 (2021).
33 Cho, S. C. et al. Protective effect of 4,4'-diaminodiphenylsulfone against paraquat-induced mouse lung injury. Exp Mol Med43, 525-537, doi:10.3858/emm.2011.43.9.060 (2011).
34 Mahale, A. et al. Dapsone prolong delayed excitotoxic neuronal cell death by interacting with proapoptotic/survival signaling proteins. J Stroke Cerebrovasc Dis29, 104848, doi:10.1016/j.jstrokecerebrovasdis.2020.104848 (2020).
35 Zhan, R. et al. Dapsone protects brain microvascular integrity from high-fat diet induced LDL oxidation. Cell Death Dis9, 683, doi:10.1038/s41419-018-0739-y (2018).
36 Rashidian, A. et al. Dapsone reduced acetic acid-induced inflammatory response in rat colon tissue through inhibition of NF-kB signaling pathway. Immunopharmacol Immunotoxicol41, 607-613, doi:10.1080/08923973.2019.1678635 (2019).
37 De Cesare, V. et al. Deubiquitinating enzyme amino acid profiling reveals a class of ubiquitin esterases. Proc. Natl. Acad. Sci. U. S. A.118, e2006947118 (2021).
38 Clague, M. J., Urbe, S. & Komander, D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat. Rev. Mol. Cell Biol.20, 338-352 (2019).
39 Burslem, G. M. & Crews, C. M. Proteolysis-targeting chimeras as therapeutics and tools for biological discovery. Cell181, 102-114 (2020).
40 Polack, F. P. et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med383, 2603-2615, doi:10.1056/NEJMoa2034577 (2020).
41 Wang, Z. et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature592, 616-622 (2021).
42 Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nature Reviews Drug Discovery, doi:10.1038/s41573-021-00283-5 (2021).
43 Nathan, A. et al. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses. Cell184, 4401-4413.e4410, doi:10.1016/j.cell.2021.06.029 (2021).
44 Organization, W. H. Protocol template to be used as template for observational study protocols: sentinel surveillance of adverse events of special interest (AESIs) after vaccination with COVID-19 vaccines. (2021).
45 Ratajczak, M. Z. et al. SARS-CoV-2 entry receptor ACE2 is expressed on very small CD45− precursors of hematopoietic and endothelial cells and in response to virus spike protein activates the Nlrp3 inflammasome. Stem Cell Reviews and Reports17, 266-277 (2021).
46 Levin, D. et al. Myocarditis following COVID-19 vaccination – a case series. Vaccine, doi:https://doi.org/10.1016/j.vaccine.2021.09.004 (2021).
47 Barda, N. et al. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. New England Journal of Medicine, doi:10.1056/NEJMoa2110475 (2021).
48 Ehrlich, P. et al. Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clinical Research in Cardiology, doi:10.1007/s00392-021-01936-6 (2021).
49 Muniyappa, R. & Gubbi, S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. American Journal of Physiology-Endocrinology and Metabolism318, E736-E741, doi:10.1152/ajpendo.00124.2020 (2020).